145 studies found for:    Non-Alcoholic Steatohepatitis
Show Display Options
Rank Status Study
21 Completed Efficacy and Safety of Diamel in Patients With Nonalcoholic Steatohepatitis
Conditions: Nonalcoholic Steatohepatitis;   Insulin Resistance
Interventions: Dietary Supplement: Diamel;   Other: Placebo and lifestyle counseling
22 Completed Efficacy and Safety of Viusid in Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Dietary Supplement: Viusid;   Other: Hypocaloric Diet with controlled exercise
23 Unknown  Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH
Conditions: Nonalcoholic Steatohepatitis;   Liver Diseases
Intervention: Drug: Pentoxifylline
24 Completed Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH)
Condition: Non Alcoholic Steatohepatitis
Interventions: Procedure: AHA diet plus exercise with BIB placement;   Procedure: AHA diet plus exercise with sham BIB placement
25 Recruiting Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
Conditions: Fatty Liver Disease, Nonalcoholic;   Nonalcoholic Steatohepatitis;   Lipodystrophy
Intervention: Drug: Metreleptin
26 Unknown  Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)
Conditions: Nonalcoholic Steatohepatitis;   Nonalcoholic Fatty Liver Disease
Interventions: Drug: avandia;   Drug: metformin;   Drug: losartan
27 Recruiting Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis
Condition: Non Alcoholic Steatohepatitis
Intervention: Drug: Ezetimibe
28 Active, not recruiting Pentoxiphylline and Vitamin E Versus Vitamin E in Patients With Non- Alcoholic Steatohepatitis
Condition: Non Alcoholic Steatohepatitis
Interventions: Drug: pentoxiphylline and Vitamin E;   Drug: Vitamin E
29 Completed A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis
Condition: Non Alcoholic Steatohepatitis
Intervention: Drug: rosiglitazone
30 Completed Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: Pioglitazone;   Drug: Placebo
31 Unknown  Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes
Conditions: Type 2 Diabetes;   Nonalcoholic Steatohepatitis
Interventions: Drug: sitagliptin;   Drug: placebo
32 Completed Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: GS-9450;   Drug: GS-9450 Placebo
33 Enrolling by invitation Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Intervention: Drug: Colesevelam Hcl
34 Completed Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers
Conditions: Hepatic Cirrhosis;   Nonalcoholic Steatohepatitis
Intervention: Drug: NRL972
35 Completed Pharmacokinetics of NRL972 in Patients With Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD)
Conditions: Non-Alcoholic Fatty Liver Disease;   Nonalcoholic Steatohepatitis
Intervention: Other: NRL972
36 Withdrawn Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Biological: IMM 124-E;   Biological: Placebo
37 Completed The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis
Condition: Non Alcoholic Steatohepatitis
Interventions: Dietary Supplement: synbiotic;   Other: placebo
38 Unknown  Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis
Conditions: Sleep Apnea Syndrome;   Nonalcoholic Steatohepatitis
Intervention: Device: nCPAP
39 Unknown  Vitamin E Versus Vitamin E Plus Pentoxiphyllin in Patients With Nonalcoholic Steatohepatitis: A Prospective Randomized Clinical Trial
Condition: Non Alcoholic Steatohepatitis
Interventions: Drug: Vitamin E plus Pentoxiphyllin;   Drug: Vitamin E
40 Recruiting Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Biological: Simtuzumab 700mg;   Biological: Simtuzumab 200mg;   Biological: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years